among
member
secret
phospholipas
spla
famili
group
iid
iie
iif
iii
spla
spla
iid
iie
iif
iii
respect
new
isoform
histori
spla
research
rel
better
character
spla
spla
ib
iia
v
x
enzymat
properti
distribut
function
new
spla
remain
obscur
recent
current
studi
use
knockout
transgen
mice
nearli
full
set
spla
combin
comprehens
lipidom
reveal
uniqu
distinct
role
new
spla
specif
biolog
event
thu
spla
iid
involv
immun
suppress
spla
iie
metabol
regul
hair
follicl
homeostasi
spla
iif
epiderm
hyperplasia
spla
iii
male
reproduct
anaphylaxi
colon
diseas
possibl
atherosclerosi
articl
overview
current
understand
properti
function
spla
underli
lipid
pathway
vivo
alreadi
describ
review
special
issu
secret
pla
spla
famili
contain
catalyt
activ
isoform
ib
iia
iic
iid
iie
iif
iii
v
x
xiia
one
inact
isoform
xiib
mammal
individu
spla
exhibit
uniqu
tissu
cellular
distribut
substrat
select
suggest
distinct
biolog
role
histor
spla
ib
iia
purifi
clone
spla
iic
v
identifi
genom
sequenc
locu
close
spla
iia
gene
soon
afterward
period
spla
hunt
research
earli
spla
iid
iie
iif
iii
x
well
two
spla
xii
isoform
identifi
est
databas
search
new
spla
lambeau
guest
editor
special
issu
group
well
other
anoth
spla
relat
protein
call
inner
ear
structur
protein
contain
two
catalyt
inact
spla
like
domain
among
new
spla
spla
iid
iie
iif
classifi
convent
spla
group
iiivx
close
relat
lowmolecularweight
enzym
highli
conserv
ca
bind
loop
hisasp
catalyt
dyad
well
conserv
disulfid
bond
specif
member
group
ii
subfamili
spla
spla
iia
iic
well
spla
v
belong
gene
group
ii
subfamili
spla
cluster
chromosom
locu
chromosom
human
mous
respect
suggest
origin
common
ancestr
gene
contrast
spla
iii
atyp
spla
show
closer
similar
bee
venom
group
iii
spla
mammalian
spla
evolut
group
ii
subfamili
spla
exist
vertebr
spla
group
iii
branch
present
vertebr
insect
nematod
although
current
known
spla
inhibitor
inhibit
convent
spla
variou
degre
agent
specif
inhibit
spla
iii
spla
xiia
anoth
class
atyp
spla
yet
becom
avail
although
properti
function
spla
ib
iia
v
x
see
review
special
issu
describ
tabl
biolog
function
spla
iid
iie
iif
iii
reveal
studi
use
knockout
ko
transgen
tg
mice
reduct
ch
psoriasi
increas
antitumor
immun
protect
skin
cancer
decreas
antitumor
immun
product
pgd
increas
antivir
immun
protect
sarsinduc
pneumonia
nd
spla
iie
adipocyt
hydrolysi
minor
lipoprotein
phospholipid
eg
protect
dietinduc
obes
hyperlipidemia
nd
unknown
agerel
fat
accumul
reduc
lipolysi
nd
hair
follicl
releas
variou
unsatur
fatti
acid
lpe
speci
modest
abnorm
hair
follicl
nd
spla
iif
suprabas
keratinocyt
product
lysoplasmalogen
protect
psoriasi
ch
skin
cancer
spontan
develop
psoriasislik
epiderm
hyperplasia
alopecia
exacerb
skin
cancer
spla
iii
epididym
epitheli
cell
sperm
membran
phospholipid
remodel
male
hypofertil
nd
mast
cell
product
microenvironment
pgd
impair
mast
cell
matur
anaphylaxi
increas
mast
cell
matur
anaphylaxi
colon
epitheli
cell
product
lpa
lpi
protect
colon
cancer
coliti
nd
aorta
gener
lpcrich
smalldens
ldl
nd
exacerb
atherosclerosi
skin
product
pge
nd
spontan
skin
inflamm
nd
done
result
tg
overexpress
numer
studi
spla
remain
poorli
understood
decad
recent
seri
studi
use
knockout
transgen
mice
nearli
full
set
spla
togeth
comprehens
lipidom
approach
identifi
cognat
substrat
phospholipid
product
fatti
acid
lysophospholipid
metabolit
clarifi
distinct
biolog
role
vivo
although
gene
group
ii
subfamili
spla
cluster
chromosom
locu
phenotyp
observ
knockout
mice
individu
spla
distinct
see
impli
compensatori
function
review
provid
overview
current
knowledg
properti
function
spla
iid
iie
iif
iii
role
spla
underli
lipidmetabol
pathway
summar
tabl
gener
aspect
spla
iid
similar
spla
iia
homolog
spla
identifi
three
group
lambeau
group
hanasaki
group
independ
identifi
mous
human
enzym
est
databas
search
anoth
group
isol
spla
iid
call
splash
subtract
clone
splenic
cdna
wildtyp
wt
lymphotoxindefici
mice
profound
defect
splenic
microarchitectur
similar
spla
iia
spla
iid
basic
protein
made
amino
acid
cystein
exactli
conserv
posit
like
cation
natur
spla
iid
bind
heparin
vitro
heparan
sulfat
cell
surfac
overexpress
cultur
cell
initi
studi
reveal
recombin
spla
iid
rather
lower
enzymat
activ
spla
iia
assay
use
phospholipid
vesicl
oleic
acid
oa
linol
acid
la
posit
transfect
spla
iid
cultur
cell
eg
cell
abl
augment
arachidon
acid
aa
releas
prostaglandin
e
pge
gener
albeit
lower
potenc
spla
iia
howev
properti
need
interpret
caution
sinc
pla
enzym
assay
employ
artifici
phospholipid
vesicl
compris
one
phospholipid
speci
cellbas
studi
spla
artifici
overexpress
excess
spla
ad
superphysiolog
level
necessarili
reflect
true
function
aspect
vivo
comprehens
understand
pathophysiolog
function
spla
import
consid
degre
given
spla
express
phospholipid
speci
given
membran
compon
serv
target
substrat
lipid
metabolit
gener
lipid
metabolit
modul
biolog
respons
relev
tissu
microenviron
becom
obviou
function
spla
limit
regul
aa
metabol
use
classic
view
pla
research
also
associ
mobil
variou
fatti
acid
lysophospholipid
specif
tissu
context
describ
spla
iid
express
mainli
dendrit
cell
dc
macrophag
particularli
mhc
class
ii
lo
dc
macrophag
secondari
lymphoid
organ
spleen
lymph
node
ln
mice
human
oppos
spla
iia
socal
inflammatori
spla
whose
express
upregul
variou
tissu
respons
proinflammatori
cytokin
lipopolysaccharid
lp
spla
iid
downregul
antigenactiv
mhc
class
ii
hi
dc
lpsstimul
tissu
macrophag
new
lipidomicsbas
pla
enzym
assay
use
natur
phospholipid
mixtur
extract
relev
tissu
lymphoid
tissu
case
spla
iid
substrat
natur
membran
assay
reveal
spla
iid
preferenti
hydrolyz
phosphatidylethanolamin
pe
speci
polyunsatur
fatti
acid
pufa
includ
aa
effici
eicosapentaeno
acid
epa
docosahexaeno
acid
dha
rather
oa
la
enzymat
prefer
spla
iid
pe
speci
pufa
substrat
togeth
distribut
lymphoid
immun
cell
downregul
proinflammatori
stimuli
suggest
spla
iid
role
resolut
rather
promot
adapt
immun
respons
possibl
spla
iid
might
immunosuppress
function
first
demonstr
research
field
cell
biolog
von
allmen
et
al
found
among
variou
cell
subset
spla
iid
select
express
reg
cell
capac
promot
reg
differenti
function
although
subsequ
studi
shown
spla
iid
express
much
abundantli
antigenpres
cell
dc
macrophag
reg
cell
interestingli
spla
iidfc
fusion
protein
inhibit
prolifer
effector
cell
vitro
suppress
diseas
coliti
multipl
sclerosi
administ
mice
howev
remain
uncertain
whether
system
administ
artifici
spla
iidfc
fusion
protein
inde
mirror
intrins
function
endogen
spla
iid
even
enzym
exert
immunoregulatori
function
although
spla
iidfc
fusion
protein
might
act
spla
receptor
spla
iid
poor
bind
affin
overal
bind
properti
variou
spla
detail
review
special
issu
beyond
possibl
spla
iid
could
transmit
signal
bind
unknown
receptor
rule
distinct
effect
due
enzymat
activ
versu
receptoroper
mechan
address
use
catalyt
mutant
spla
iid
includ
knockin
mice
spla
iid
mutant
nonetheless
immunosuppress
function
spla
iid
establish
seri
recent
studi
use
spla
iiddefici
transgen
mice
describ
model
contact
hypersensit
ch
applic
hapten
antigen
dinitrofluorobenzen
dnfb
abdomin
skin
sensit
follow
second
applic
antigen
ear
skin
elicit
induc
ear
swell
elicit
phase
ch
resolut
propag
inflamm
skin
ln
delay
mice
state
express
level
signatur
cytokin
highli
elev
drain
ln
wherea
reg
marker
unaffect
spla
iid
defici
even
late
stage
sensit
phase
express
ln
substanti
elev
mice
moreov
dc
isol
mice
hyperactiv
even
absenc
stimul
increas
secret
elev
surfac
express
mhc
class
ii
contrast
acut
skin
inflamm
evalu
irrit
dermat
affect
spla
iid
defici
result
suggest
lack
spla
iid
augment
dcmediat
immun
rather
influenc
reg
cell
function
neutrophilmedi
acut
inflamm
psoriasi
common
chronic
skin
diseas
western
countri
character
epiderm
hyperplasia
acanthosi
scale
erythemat
plaqu
format
due
aberr
prolifer
differenti
activ
keratinocyt
well
activ
immun
model
imiquimod
imq
induc
psoriasi
mice
display
sever
epiderm
hyperplasia
mice
increas
cell
affect
skin
region
ln
furthermor
dc
mice
produc
greater
amount
play
pivot
role
immun
wt
mice
convers
mice
display
milder
inflamm
ch
psoriasi
model
thu
spla
iid
suppress
adapt
immun
respons
ch
psoriasi
respect
concept
appear
corrobor
abil
spla
iidfc
fusion
serva
seven
day
last
immun
left
right
ear
mice
inject
intraderm
ova
ear
swell
measur
min
ova
challeng
total
ovaspecif
ige
level
sera
measur
elisa
bethyl
laboratori
ovainduc
ige
level
ear
edema
elev
mice
rel
mice
n
mean
sem
p
p
b
lipidom
heat
map
profil
aaand
epadhaderiv
lipid
mediat
lymph
node
ko
mice
rel
wt
mice
epadhaderiv
lipid
mediat
decreas
ko
mice
elev
sever
aa
metabolit
ko
mice
might
due
increas
lymph
node
inflamm
hete
hydroxyeicosatetraeno
acid
hepe
hydroxyeicosapentaeno
acid
hdha
hydroxydocosahexaeno
acid
lx
lipoxin
pd
protectin
rv
resolvin
c
lung
histolog
wt
mice
male
week
old
lung
mice
pronounc
leukocyt
infiltr
wt
mice
age
week
old
young
week
old
mice
circul
granulocyt
agematch
wt
mice
mean
sem
p
result
c
suggest
increas
immunosuppress
tone
tg
mice
result
opportunist
infect
therebi
airway
inflamm
e
schemat
diagram
spla
iid
action
lymphoid
tissu
spla
iid
preferenti
express
dc
hydrolyz
pe
microparticl
provid
epadhaderiv
proresolv
lipid
mediat
structur
shown
dampen
adapt
immun
spla
iid
amelior
inflamm
ch
psoriasi
perturb
host
defens
infect
cancer
protein
suppress
coliti
multipl
sclerosi
typic
diseas
model
address
whether
spla
iid
would
also
affect
immun
sensit
litterm
mice
ovalbumin
ova
intraperiton
challeng
antigen
ear
model
activ
cutan
anaphylaxi
serum
level
total
ovaspecif
ige
well
ear
swell
significantli
increas
ovachalleng
mice
rel
mice
fig
sinc
passiv
cutan
anaphylaxi
affect
absenc
spla
iid
like
increas
activ
anaphylact
respons
mice
due
increas
level
ovaspecif
ige
indic
increas
respons
therebi
hyperactiv
mast
cell
sensit
ige
rather
attribut
intrins
alter
mast
cell
vascular
endotheli
cell
thu
immun
also
immun
respons
suppress
spla
iid
lipidom
analys
region
ln
spleen
spla
iid
abundantli
express
reveal
steadyst
level
pufa
markedli
reduc
mice
rel
mice
moreov
level
pufa
metabolit
dhaderiv
resolvin
markedli
lower
ln
ln
fig
convers
level
pufa
metabolit
elev
ln
mice
rel
wt
mice
contrast
ln
level
eicosanoid
prostanoid
leukotrien
bare
alter
even
elev
spla
iid
delet
impli
aa
metabolit
larg
deriv
spla
iidindepend
aa
pool
possibl
action
cytosol
pla
cpla
pla
subtyp
togeth
substrat
select
describ
like
spla
iid
preferenti
constitut
hydrolyz
pufacontain
pe
speci
ln
membran
probabl
microparticl
case
spla
iia
mobil
pufaderiv
antiinflammatori
lipid
mediat
put
brake
dccommit
adapt
immun
report
leukocytederiv
microparticl
spatiotempor
gener
inflammatori
exud
resolut
contain
esterifi
phospholipid
precursor
antiinflammatori
lipid
mediat
therefor
specul
similar
microparticl
constitut
gener
lymphoid
tissu
might
target
spla
iid
although
hypothesi
need
elucid
grow
bodi
evid
indic
pufaderiv
resolvin
includ
capac
suppress
acquir
immun
attenu
migrat
activ
dc
antigen
present
cell
ige
class
switch
b
cell
furthermor
consist
view
pufa
metabolit
maresin
facilit
antiinflammatori
polar
macrophag
splenic
ratio
macrophag
decreas
mice
rel
wt
mice
collect
spla
iid
resolv
spla
preferenti
mobil
pufa
metabolit
lymphoid
organ
therebi
amelior
aggrav
adapt
immun
note
spla
iid
pufareleas
spla
vivo
inde
pufa
releas
spla
x
colon
spermatozoa
spla
iif
skin
spla
tissuespecif
role
see
although
spla
iid
prevent
exagger
immun
ch
psoriasi
benefici
immunosuppress
properti
convers
disadvantag
circumst
host
defens
infect
cancer
inde
spla
iid
prevent
antivir
antitumor
immun
eventu
exacerb
viral
infect
tumor
develop
toward
wors
outcom
spla
iid
express
lung
dc
increas
age
respons
chronic
exposur
oxid
stress
age
month
old
mice
spla
iid
contribut
exacerb
rather
amelior
pneumonia
caus
infect
sar
coronaviru
influenza
viru
situat
spla
iid
coupl
pulmonari
mobil
prostaglandin
pgd
antiinflammatori
aa
metabolit
context
block
dc
migrat
therebi
antivir
respons
receptor
accordingli
mice
show
increas
migrat
lung
dc
ln
lead
augment
antivir
cell
respons
protect
infectioninduc
lung
inflamm
death
although
test
studi
conceiv
steadyst
reduct
pufa
metabolit
ln
mice
see
may
also
contribut
increas
antivir
immun
set
consist
notion
age
month
old
mice
show
profound
leukocyt
infiltr
lung
fig
granulocyt
circul
fig
agematch
wt
mice
suggest
increas
immunosuppress
tone
overexpress
spla
iid
result
opportunist
infect
therebi
lung
inflamm
likewis
spla
iid
acceler
rather
prevent
develop
skin
tumor
like
enzym
attenu
antitumor
immun
model
chemic
carcinogenesi
mice
highli
protect
develop
skin
cancer
accompani
increas
cytotox
cell
macrophag
well
decreas
tumorpromot
macrophag
convers
transgen
overexpress
spla
iid
shift
immun
balanc
toward
suppress
antitumor
immun
reportedli
ectop
administr
pufa
metabolit
system
overproduct
lipid
mice
transgen
pufa
synthas
caenorhabd
elegan
confer
protect
effect
infectionbas
inflamm
cancer
xenograft
facilit
phagocytot
clearanc
detriment
materi
neutrophil
macrophag
apart
system
effect
pufa
spatiotempor
suppli
pufa
spla
iid
local
lymphoid
nich
may
distinct
impact
adapt
immun
suppress
function
dc
cell
taken
togeth
immunosuppress
function
spla
iid
provid
favor
unfavor
outcom
distinct
diseas
set
protect
inflamm
exacerb
infect
cancer
fig
point
potenti
prophylact
therapeut
use
agent
would
specif
stabil
inhibit
enzym
accord
diseas
context
particular
specif
inhibit
spla
iid
patient
sever
respiratori
infect
certain
type
cancer
would
potenti
attract
therapeut
intervent
restor
immunolog
function
concept
reminisc
immun
checkpoint
therapi
chronic
obstruct
pulmonari
diseas
copd
major
caus
morbid
mortal
worldwid
lifethreaten
diseas
creat
problem
result
airflow
obstruct
also
major
impact
cardiac
function
air
exchang
therebi
result
system
manifest
presenc
chronic
system
inflammatori
respons
import
influenc
patient
surviv
unexplain
weight
loss
due
muscl
wast
adipos
tissu
deplet
characterist
featur
advanc
copd
link
system
inflamm
interestingli
polymorph
human
spla
iid
gene
associ
bodi
weight
loss
patient
copd
copd
patient
carri
spla
iid
lose
signific
amount
bodi
weight
comparison
carri
spla
iid
although
mutat
affect
vitro
enzymat
activ
spla
iid
enhanc
express
cell
human
pulmonari
epitheli
cell
line
molecular
model
human
spla
iid
reveal
substanti
differ
nativ
mutant
form
term
channel
open
surfac
area
interfaci
bind
contact
given
immunosuppress
properti
spla
iid
describ
mutant
form
might
weaker
abil
nativ
form
suppress
inflamm
also
possibl
bodi
weight
loss
could
relat
antiinflammatori
function
spla
iid
metabol
activ
tissu
eg
adipos
tissu
describ
elsewher
mous
human
spla
iie
identifi
lambeau
group
hanasaki
group
est
databas
spla
iie
consist
amino
acid
similar
spla
iia
respect
number
posit
cystein
residu
well
overal
pe
pg
pi
ps
molecular
speci
elev
ldl
ko
mice
suggest
spla
iie
act
minor
lipoprotein
phospholipid
appar
fatti
acid
select
b
schemat
diagram
spla
iiedriven
lipid
pathway
lipoprotein
metabol
obes
obes
spla
iie
induc
adipocyt
hydrolyz
minor
lipoprotein
phospholipid
promot
obes
hyperlipidemia
role
lysophospholipid
releas
spla
iie
unknown
c
situ
hybrid
spla
iie
mous
skin
intens
signal
local
hair
follicl
ident
homolog
similar
group
ii
subfamili
spla
except
spla
iif
see
spla
iie
basic
protein
show
weak
affin
heparin
within
limit
overexpress
strategi
use
cultur
cell
abil
spla
iie
elicit
aa
releas
weaker
spla
iid
valentin
et
al
report
enzymat
activ
spla
iie
much
weaker
spla
wherea
suzuki
et
al
shown
activ
spla
iie
compar
spla
iia
hydrolyz
pe
lesser
extent
phosphatidylcholin
pc
fatti
acid
select
reconcil
inconsist
two
studi
reevalu
enzymat
activ
spla
iie
use
lipidomicsbas
natur
membran
assay
phospholipid
mixtur
extract
mous
skin
tissu
spla
iie
express
abundantli
see
substrat
found
spla
iie
activ
spla
phospholipid
concentr
suffici
high
wherea
activ
weak
low
substrat
concentr
allow
spla
remain
fulli
activ
suggest
appar
k
spla
iie
toward
skinextract
phospholipid
mixtur
higher
spla
presenc
suffici
high
concentr
phospholipid
spla
iie
capabl
releas
variou
unsatur
fatti
acid
includ
oa
la
aa
dha
well
lysphosphatidylethanolamin
lpe
prefer
lysophosphatidylcholin
lpc
pattern
similar
result
report
suzuki
et
al
substrat
select
support
crystal
structur
human
spla
iie
show
overal
similar
human
spla
iia
yet
substanti
differ
term
basic
residu
cluster
interfaci
site
ctermin
region
inbr
mous
strain
aj
pj
spla
iia
entir
absent
due
frameshift
mutat
gene
wherea
gene
function
express
larg
restrict
intestin
inbr
strain
balbc
nzb
dba
outbr
strain
instead
spla
iie
express
markedli
induc
sever
mous
tissu
upon
lp
challeng
serum
amyloid
proinflammatori
mediat
lethal
system
inflammatori
diseas
induc
spla
iie
express
mous
macrophag
contrast
spla
iie
express
bare
detect
human
tissu
lead
hypothesi
function
spla
iia
human
might
compens
spla
iie
mice
nevertheless
studi
report
spla
iie
express
human
cell
polymorph
human
spla
iie
gene
associ
ulcer
coliti
suggest
spla
iie
may
function
human
certain
situat
recent
studi
use
spla
iiedefici
mice
reveal
novel
role
spla
metabol
regul
hair
follicl
homeostasi
describ
spla
iie
highli
induc
hypertroph
white
adipocyt
mice
fed
highfat
diet
genet
obes
obob
mice
adipogen
stimulu
suffici
induct
spla
iie
adipocyt
model
dietinduc
obes
mice
modestli
protect
obes
hepat
steatosi
hyperlipidemia
lipidom
analysi
plasma
lipoprotein
obtain
mice
comparison
mice
reveal
variou
molecular
speci
pe
phosphatidylserin
ps
phosphatidylinositol
pi
phosphatidylglycerol
pg
pc
elev
null
mice
fig
suggest
spla
iie
preferenti
hydrolyz
minor
lipoprotein
phospholipid
appar
fatti
acid
select
vivo
spla
iie
metabol
spla
alter
lipid
composit
lipoprotein
therebi
moder
affect
lipid
accumul
adipos
tissu
liver
fig
howev
mechan
wherebi
spla
iiedriven
hydrolysi
minor
lipoprotein
phospholipid
link
metabol
regul
still
remain
obscur
sinc
increas
neg
charg
lipoprotein
render
particl
smaller
increas
anion
phospholipid
eg
ps
lipoprotein
result
spla
iie
defici
might
afford
effect
altern
certain
lysophospholipid
speci
produc
spla
iie
might
metabol
effect
possibl
await
futur
studi
fact
lysophosphatidylserin
lysop
lysophsophatidylinositol
lpi
act
cognat
receptor
affect
inflamm
metabol
importantli
metabol
action
spla
iie
contrast
spla
v
anoth
dietinduc
metabol
spla
hydrolyz
pc
lowdens
lipoprotein
ldl
preferenti
releas
oa
la
therebi
protect
obes
insulin
resist
fatti
liver
adipos
tissu
inflamm
hand
anoth
studi
reveal
mice
accumul
epididym
fat
mice
age
ex
vivo
adipogenesi
knockout
knockdown
spla
iie
increas
triglycerid
adipocyt
wherea
overexpress
exogen
addit
facilit
lipolysi
increas
releas
glycerol
although
reason
discrep
two
studi
unclear
might
attribut
differ
experiment
condit
dietinduc
versu
ageassoci
obes
highfat
versu
chow
diet
femal
versu
male
differ
anim
facil
one
possibl
explan
spla
iie
might
addit
effect
brown
beig
fat
therebi
lipolysi
thermogenesi
hypothesi
remain
test
hair
follicl
skin
undergo
repeat
cycl
growth
anagen
regress
catagen
rest
telogen
life
perturb
skin
lipid
metabol
variabl
often
sever
affect
hair
cycl
therebi
caus
hair
loss
alopecia
spla
iie
hair
follicular
spla
express
abundantli
hair
follicl
anagen
period
distribut
companion
cell
outer
root
sheath
cuticular
cell
inner
root
sheath
fig
mice
exhibit
mild
skin
abnorm
perturb
hair
follicl
ultrastructur
modest
chang
steadyst
express
subset
skin
gene
lipidom
analysi
reveal
spla
iie
mobil
variou
unsatur
fatti
acid
lpe
speci
acyl
plasmalogen
form
mous
skin
substrat
select
fit
well
vitro
enzymat
properti
spla
iie
see
howev
remain
unclear
lipid
metabolit
mobil
spla
iie
import
hair
follicl
homeostasi
mous
human
spla
iif
identifi
lambeau
colleagu
spla
iif
consist
amino
acid
harbor
structur
featur
group
ii
subfamili
spla
sever
uniqu
characterist
first
spla
iif
acid
protein
contrast
group
ii
subfamili
spla
basic
second
although
spla
activ
neutral
mildli
basic
condit
gener
spla
iif
retain
full
enzymat
activ
even
mildli
acid
ph
properti
may
relat
distribut
enzym
epidermi
see
mildli
acid
environ
import
proper
keratinocyt
differenti
function
third
spla
iif
uniqu
long
ctermin
extens
prolinerich
contain
singl
cystein
presenc
odd
cystein
rais
possibl
spla
iif
might
occur
coval
dimer
like
sever
venom
spla
although
experiment
confirm
fourth
spla
iif
hydrophob
spla
probabl
result
high
hydrophob
spla
iif
uniqu
abil
penetr
disrupt
lipid
monolay
bilay
vitro
rapidli
enter
cell
endocytosisindepend
manner
form
unusu
aggreg
within
limit
overexpress
strategi
spla
iif
increas
aa
releas
potenc
compar
spla
iii
superior
spla
iia
transfect
cell
human
fibroblast
rank
order
x
v
iii
iif
iia
iid
iie
natur
membran
assay
use
phospholipid
mixtur
extract
mous
skin
spla
iif
preferenti
hydrolyz
pe
particularli
plasmalogentyp
pe
ppe
yield
lysoplasmalogen
plasmalogentyp
lpe
plpe
well
dha
prefer
aa
physiolog
relev
concentr
note
although
high
concentr
spla
often
cleav
substrat
nonselect
vitro
observ
skin
lipid
hydrolysi
recombin
spla
iif
use
low
concentr
spla
could
reproduc
vivo
substrat
select
natur
membran
assay
epidermi
highli
organ
stratifi
epithelium
four
distinct
layer
compris
innermost
stratum
basal
stratum
spinosum
stratum
granulosum
outermost
stratum
corneum
sc
spla
iif
abundantli
express
suprabas
spinou
sc
layer
epidermi
cultur
keratinocyt
spla
iif
markedli
increas
cell
differenti
parallel
induct
keratinocyt
differenti
activ
marker
robustli
upregul
follow
stimul
cytokin
moreov
spla
iif
highli
express
hyperplas
epidermi
patient
psoriasi
find
indic
spla
iif
may
associ
epiderm
homeostasi
diseas
particularli
patholog
psoriasi
immun
play
crucial
role
inde
studi
use
spla
iifdefici
transgen
mice
reveal
uniqu
role
spla
iif
epiderm
spla
epiderm
hyperplas
diseas
includ
psoriasi
skin
cancer
describ
follow
psoriat
stimulu
imiquimod
spla
iif
induc
epiderm
keratinocyt
cytokin
deriv
cell
hydrolyz
plasmalogen
give
rise
lysoplasmalogen
plpe
turn
promot
epiderm
hyperplasia
inflamm
contrast
spla
iid
block
immun
lymph
node
product
pufa
metabolit
therebi
put
brake
psoriasi
b
plpe
produc
epiderm
spla
iif
promot
hypergrowth
skin
cancer
without
affect
incid
contrast
pufa
metabolit
produc
spla
iid
lymph
node
decreas
cytotox
cell
ctl
increas
tumorassoci
macrophag
tam
lead
reduc
antitumor
immun
spla
iid
facilit
tumor
format
growth
structur
plpe
shown
c
lipoprotein
profil
wt
mice
level
phospholipid
hdl
ldl
markedli
lower
mice
wt
mice
n
mean
sem
p
suggest
spla
iif
overexpress
systemat
capac
hydrolyz
lipoprotein
phospholipid
circul
ldl
fraction
magnifi
inset
vldl
verylowdens
lipoprotein
hdl
highdens
lipoprotein
cm
chylomicron
perturb
epiderm
lipid
variabl
often
profoundli
affect
skin
homeostasi
barrier
function
lead
skin
disord
ichthyosi
psoriasi
atop
dermat
cancer
prior
discoveri
epiderm
express
spla
iif
recogn
sever
spla
express
mous
human
skin
interestingli
transgen
overexpress
human
spla
iia
spla
x
mice
led
epiderm
hyperplasia
alopecia
although
endogen
express
two
spla
scarc
detect
mous
skin
later
shown
global
skinspecif
mice
spontan
develop
psoriasislik
epiderm
hyperplasia
alopecia
increas
express
panel
psoriasi
marker
includ
therefor
skin
phenotyp
observ
mice
may
indic
spla
iia
x
mimic
intrins
action
spla
iif
artifici
overexpress
skin
endogen
spla
iif
upregul
hyperplas
epidermi
tg
mice
mice
exhibit
mild
skin
abnorm
basal
state
character
fragil
stratum
corneum
modest
perturb
skin
barrier
function
acid
phenotyp
evid
abdomin
dorsal
skin
adult
newborn
mice
suggest
spla
iif
contribut
sc
stabil
environment
stress
friction
floor
prolong
exposur
skin
microbiota
rather
central
program
epiderm
differenti
tapestrip
corneum
mice
display
delay
recoveri
skin
barrier
damag
suggest
spla
iif
acceler
epiderm
repair
impact
spla
iif
ablat
dramat
primari
keratinocyt
cell
fail
differenti
undergo
proper
activ
spla
iif
genet
pharmacolog
inactiv
profound
effect
spla
iif
delet
keratinocyt
vitro
vivo
suggest
mechan
compens
lack
spla
iif
might
exist
vivo
strikingli
patholog
condit
mice
protect
epiderm
hyperplasia
model
psoriasi
ch
primari
keratinocyt
mice
express
sever
psoriasi
marker
markedli
impair
mechanist
spla
iif
hydrolyz
ppe
secret
keratinocyt
yield
plpe
uniqu
lysophospholipid
facilit
differenti
activ
keratinocyt
lead
propag
skin
inflamm
inde
level
plpe
skin
correl
well
express
level
spla
iif
multipl
skin
diseas
model
topic
applic
plpe
skin
vivo
supplement
keratinocyt
plpe
ex
vivo
restor
psoriasisrel
phenotyp
thu
patholog
psoriasi
spla
iif
play
exacerb
role
promot
aberr
prolifer
activ
keratinocyt
product
plpe
suprabas
epidermi
wherea
spla
iid
play
resolv
role
reduc
harm
immun
respons
product
pufaderiv
proresolv
mediat
lymphoid
tissu
see
fig
skinspecif
mice
sensit
chemic
carcinogenesi
even
though
endogen
spla
iia
express
mous
skin
likewis
mice
highli
suscept
skin
carcinogenesi
model
appar
propens
develop
larger
tumor
wt
mice
impli
overexpress
spla
iia
mice
mimic
action
spla
iif
importantli
mice
balbc
background
markedli
protect
develop
skin
tumor
accompani
lower
product
plpe
unalt
product
canon
aa
metabolit
among
spla
knockout
mous
strain
test
far
mice
protect
skin
cancer
distinct
mechan
spla
iid
defici
increas
antitumor
immun
therebi
block
tumor
develop
see
wherea
spla
iif
defici
amelior
keratinocyt
hyperprolifer
fig
taken
togeth
find
far
suggest
spla
iif
promot
epiderm
hyperplas
diseas
includ
psoriasi
skin
cancer
plpe
primari
spla
iif
product
repres
particular
biomark
bioactiv
lipid
reflect
express
function
spla
iif
given
spla
iif
express
epidermi
rather
specif
mice
display
profound
skin
phenotyp
patholog
condit
physiolog
condit
block
neutral
particular
spla
may
novel
approach
specif
treatment
psoriasi
skin
cancer
condit
character
epiderm
hyperplasia
remain
clarifi
whether
spla
iifdriven
plpe
would
act
keratinocyt
specif
receptor
mechan
whether
dha
anoth
spla
iifdriven
product
would
metabol
certain
product
would
affect
skin
homeostasi
latter
possibl
seem
plausibl
sinc
dha
metabolit
shown
capac
facilit
skin
wound
heal
suppress
psoriasi
prevent
neoplast
transform
keratinocyt
recombin
spla
iif
potent
capac
prevent
malaria
infect
vitro
antimalaria
properti
spla
depend
abil
releas
pufa
rel
fatti
acid
lipoprotein
spla
iif
pufaselect
spla
inde
lipoprotein
phospholipid
potent
hydrolyz
mark
pufa
prefer
treat
spla
iif
vitro
mice
vivo
fig
beyond
abil
confer
antimalaria
immun
lipoprotein
hydrolysi
spla
would
expect
influenc
system
metabol
demonstr
metabol
spla
spla
iie
v
see
context
would
import
determin
whether
endogen
spla
iif
opportun
encount
plasma
lipoprotein
certain
vivo
condit
cell
tissu
would
secret
spla
iif
context
spla
iifdirect
lipoprotein
hydrolysi
would
affect
immun
metabol
although
spla
iif
also
substanti
express
intestin
epithelium
defici
significantli
alter
sensit
coliti
anim
model
human
spla
iii
origin
identifi
lambeau
colleagu
spla
iii
atyp
spla
whose
structur
rather
distinct
convent
group
iiivx
spla
except
conserv
catalyt
site
ca
bind
motif
human
spla
iii
amino
acid
made
central
spla
domain
residu
typic
group
iii
featur
flank
uniqu
nand
ctermin
domain
residu
respect
gene
map
chromosom
central
spla
domain
similar
bee
venom
spla
possess
featur
group
iii
spla
includ
cystein
unlik
spla
ib
x
ntermin
propeptid
interfer
catalyt
activ
presenc
nand
ctermin
domain
profoundli
affect
activ
spla
iii
molecular
model
spla
domain
reveal
spla
iii
uniqu
structur
featur
comparison
convent
spla
decreas
volum
substratebind
hydrophob
channel
overexpress
cell
primari
fibroblast
spla
iii
elicit
aa
releas
potenc
compar
spla
iif
superior
spla
iia
nand
ctermin
domain
remov
give
rise
matur
spla
domainonli
form
overexpress
spla
iii
mammalian
insect
cell
often
nglycosyl
two
posit
affect
secret
enzym
although
nglycosyl
endogen
spla
iii
yet
confirm
vivo
evalu
enzymat
properti
use
lipidomicsbas
natur
membran
assay
mixtur
colonextract
phospholipid
substrat
demonstr
spla
iii
hydrolyz
phospholipid
subclass
includ
pc
pe
ps
pi
pg
ie
appar
polar
head
group
specif
tend
prefer
posit
pufa
mice
spla
iii
distribut
sever
tissu
show
highest
express
colon
skin
male
reproduct
organ
inde
mice
null
spla
iii
transgen
overexpress
human
spla
iii
display
sever
remark
phenotyp
tissu
describ
importantli
studi
reveal
spla
may
work
differ
tissu
differ
mechan
differ
biolog
effect
complex
process
testicular
germ
cell
differenti
spermatozoa
exit
seminifer
tubul
testi
epididymi
epididym
transit
spermatozoa
pc
sperm
membran
undergo
dramat
shift
acyl
group
oa
aa
dha
docosapentaeno
acid
dpa
increas
proport
dpadha
consequ
contribut
increas
sperm
membran
fluiditi
therebi
flagellar
motil
oocyt
fertil
percentag
dha
rel
total
fatti
acid
correl
normal
morpholog
fertil
sperm
cell
male
hypofertil
mice
highlight
critic
role
spla
iii
epididym
sperm
matur
process
fact
mutant
male
mate
wt
femal
litter
size
reduc
genotyperel
manner
pup
per
litter
breed
male
femal
spla
iii
express
epididym
epitheli
cell
well
testicular
sertoli
cell
epididymi
spla
iii
secret
epithelium
lumen
act
immatur
sperm
cell
pass
duct
paracrin
manner
regul
phospholipid
remodel
strikingli
sperm
membran
phospholipid
remodel
epididymi
testicular
spermatogenesi
sever
compromis
mice
accordingli
spermatozoa
low
proport
dpadha
aberr
acrosom
abnorm
axonem
configur
flagella
result
reduc
motil
fertil
epididym
spla
iii
may
particip
deacyl
oa
aa
sperm
phospholipid
follow
reacyl
dha
dpa
certain
lysophospholipid
acyltransferas
possibl
lead
increas
dpadhacontain
pc
matur
sperm
cell
epididymi
impair
deacyl
step
may
eventu
perturb
subsequ
reacyl
dpadha
culmin
asthenozoospermia
phenotyp
addit
mice
spla
xdefici
mice
also
display
sperm
abnorm
mice
spermatogenesi
epididym
sperm
matur
occur
normal
subsequ
sperm
activ
includ
acrosom
reaction
impair
thu
affect
fertil
spla
x
secret
sperm
acrosom
select
hydrolyz
dpadhabear
pc
speci
sperm
membran
releas
dpa
dha
lpc
among
dpa
lesser
extent
lpc
restor
fertil
capac
sperm
thu
spla
iii
promot
epididym
sperm
matur
allow
enrich
dpadhacontain
pc
speci
sperm
membran
spla
x
act
dpadharich
phospholipid
liber
dpa
lpc
success
fertil
thu
underscor
eleg
cooper
two
reproduct
spla
process
male
reproduct
clinic
standpoint
spla
iii
x
potenti
target
develop
male
contracept
agent
potenti
diagnost
marker
male
steril
well
establish
cpla
essenti
product
pgd
leukotrien
mast
cell
key
effector
cell
popul
allergi
beyond
hypothesi
spla
iii
might
particip
mast
cell
activ
allergi
stem
primarili
fact
enzym
sole
mammalian
homolog
bee
venom
spla
potent
mast
cell
activ
anaphylaxi
induc
inde
like
bee
venom
spla
exogen
human
spla
iii
elicit
mast
cell
activ
inject
mous
skin
endogen
spla
iii
express
mous
human
mast
cell
store
secretori
granul
releas
upon
cell
activ
detail
analysi
mice
reveal
spla
iii
mere
act
mast
cell
activ
also
function
essenti
regul
mast
cell
matur
microenvironment
alter
mast
cell
phenotyp
intercellular
commun
fibroblast
affect
suscept
allergi
howev
mechan
underli
matur
mast
cell
toward
allergysensit
phenotyp
remain
incomplet
understood
mast
celldepend
passiv
activ
anaphylact
respons
markedli
attenu
mice
convers
augment
mice
cellautonom
manner
skin
mast
cell
mice
morpholog
function
immatur
markedli
lower
histamin
proteas
content
secretori
granul
express
mast
cell
matur
marker
cell
surfac
express
moreov
bone
marrowderiv
mast
cell
rel
immatur
mast
cell
popul
prepar
mice
exhibit
impair
fibroblastdriven
matur
therebi
igedepend
even
independ
activ
ex
vivo
cultur
importantli
similar
mast
cell
abnorm
also
evid
mice
lack
lipocalintyp
pgd
synthas
lpgd
lack
pgd
receptor
inde
genet
pharmacolog
inactiv
mast
cell
lpgd
fibroblast
phenocopi
spla
iii
mast
cell
toward
defect
mast
cell
matur
anaphylaxi
collect
spla
iii
secret
immatur
mast
cell
function
coupl
fibroblast
lpgd
provid
microenvironment
pool
pgd
turn
act
mast
cell
promot
appropri
matur
fig
pgd
depend
paracrin
circuit
involv
spla
iii
lpgd
explain
miss
link
requir
fibroblastdriven
matur
mast
cell
accordingli
new
agent
specif
inhibit
uniqu
spla
may
use
treatment
patient
mast
cellassoci
allerg
diseas
note
howev
mast
cell
defect
observ
mice
lack
spla
iii
tend
sever
observ
mice
lack
lpgd
suggest
full
matur
mast
cell
may
requir
addit
spla
iiidriven
lipid
signal
colorect
cancer
frequent
form
malign
major
caus
death
western
hemispher
sporad
colon
cancer
exhibit
aspect
inflamm
pathogenesi
type
colon
cancer
associ
inflammatori
bowel
diseas
sever
line
evid
suggest
potenti
link
spla
iii
develop
colon
cancer
implant
spla
iiitransfect
colon
cancer
cell
nude
mice
lead
increas
growth
tumor
xenograft
spla
iii
propos
candid
biomark
human
colon
cancer
higher
express
spla
iii
human
colorect
cancer
posit
correl
higher
rate
lymph
node
metastasi
shorter
surviv
moreov
polymorph
human
spla
iii
gene
significantli
associ
higher
risk
colorect
cancer
importantli
recent
studi
spla
iii
releas
immatur
mast
cell
coupl
fibroblast
lpgd
produc
microenvironment
pool
pgd
turn
act
promot
mast
cell
matur
matur
mast
cell
express
cpla
hematopoiet
pgd
synthas
hpgd
abundantli
releas
distinct
pool
pgd
well
histamin
follow
activ
ige
antigen
lead
allerg
respons
disturb
paracrin
spla
circuit
hamper
matur
therebi
activ
mast
cell
result
impair
allerg
respons
b
role
distinct
pla
colon
cpla
releas
pool
aa
convert
pgh
pge
microsom
pge
synthas
cpla
pge
confer
protect
coliti
receptor
spla
x
releas
epadha
block
harm
respons
coliti
pufa
receptor
contrast
spla
iii
suppli
lysophospholipid
lpa
lpi
promot
coliti
colorect
cancer
probabl
receptor
lpa
respect
repres
imag
colon
wt
mice
treat
dss
mice
treat
dss
shown
c
realtim
pcr
mrna
brain
mice
n
mean
sem
result
agre
previou
report
situ
hybrid
mrna
brain
newborn
mice
signal
mrna
blue
locat
sever
neuron
within
hypothalamu
brainstem
shown
spla
iii
express
colon
epitheli
cell
genet
delet
protect
colon
cancer
coliti
mice
resist
three
distinct
model
colon
cancer
includ
induc
azoxymethan
model
carcinogeninduc
cancer
azoxymethan
plu
chronic
treatment
dextran
sulfat
sodium
dss
model
colitisinduc
cancer
apc
mutat
apc
min
model
famili
adenomat
polyposi
furthermor
mice
less
suscept
dssinduc
acut
coliti
lower
express
proinflammatori
pathogen
cytokin
higher
express
epitheli
barrier
gene
mice
impli
amelior
colon
inflamm
spla
iii
ablat
underli
protect
colon
cancer
fig
lipidom
analysi
reveal
colon
display
signific
reduct
lpa
lpi
speci
promot
colon
inflamm
cancer
receptor
lpa
respect
product
lysophospholipid
spla
iii
evid
dsstreat
steadyst
colon
suggest
spla
iii
act
labil
damag
epitheli
membran
diseas
set
colon
action
spla
iii
appear
distinct
cpla
spla
x
mobil
colonprotect
pge
pufa
respect
colon
therebi
protect
coliti
fig
overal
result
establish
role
spla
iii
aggrav
colon
inflamm
cancer
expand
understand
diverg
role
multipl
pla
enzym
colon
point
spla
iii
novel
druggabl
target
colorect
diseas
clinic
elev
plasma
level
spla
iia
independ
risk
factor
cardiovascular
diseas
propos
spla
mediat
hydrolysi
lipoprotein
phospholipid
give
rise
type
proatherogen
smalldens
ldl
increas
net
neg
charg
lpc
content
aggreg
propens
well
modifi
hdl
whose
antiatherogen
function
decreas
inde
ldl
treat
sever
spla
spla
iii
v
x
facilit
format
lipidladen
foam
cell
macrophag
hallmark
featur
atherosclerosi
vitro
basi
background
role
convent
group
iiivx
spla
atherosclerosi
investig
use
transgen
knockout
mice
sever
studi
although
result
controversi
although
varespladib
panspla
inhibitor
broadli
inhibit
convent
group
iiivx
spla
prevent
develop
atherosclerosi
anim
studi
phase
iii
clinic
trial
use
compound
fail
demonstr
therapeut
efficaci
patient
cardiovascular
diseas
like
advantag
effect
inhibit
proatherogen
spla
would
cancel
detriment
effect
inhibit
antiatherogen
spla
mice
cross
apo
mice
follow
supplement
atherogen
diet
develop
advanc
atherosclerot
lesion
apo
mice
accompani
mark
increas
proatherogen
lpcrich
smalldens
ldl
prothrombot
aa
metabolit
thromboxan
tx
mice
also
develop
system
inflamm
increas
age
suggest
elev
system
inflammatori
state
may
addit
impact
promot
atherosclerosi
mice
given
spla
iii
insensit
panspla
inhibitor
new
agent
target
atyp
spla
might
use
treatment
atherosclerosi
nonetheless
although
analysi
mice
reveal
proatherogen
potenti
spla
iii
definit
role
endogen
spla
iii
atherosclerosi
await
clarif
use
mice
potenti
role
spla
iii
express
central
nervou
system
distribut
brainstem
hypothalamu
spinal
cord
cerebr
neocortex
fig
local
spla
iii
dendrit
dendrit
spine
well
postsynapt
structur
rat
spinal
cord
suggest
potenti
role
enzym
neurotransmiss
synapt
plastic
cultur
spla
iii
promot
neuron
outgrowth
surviv
human
polymorph
associ
alzheim
diseas
potenti
role
spla
iii
neuron
function
diseas
need
evalu
use
mice
futur
studi
interestingli
function
genom
screen
identifi
spla
iii
neg
regul
ciliogenesi
primari
cilium
microtubulebas
organel
project
cell
surfac
act
antenna
sens
extracellular
cue
regul
divers
signal
pathway
defect
cilium
format
associ
mani
patholog
state
includ
classic
ciliopathi
obes
cancer
use
knockdown
strategi
propos
product
lysophospholipid
spla
iii
whose
express
control
transcript
factor
disturb
endosom
recycl
vesicular
traffick
toward
normal
ciliogenesi
therefor
function
spla
iii
inflamm
cancer
sperm
flagellar
motil
see
might
reli
least
part
regul
ciliogenesi
enzym
poorli
character
spla
spla
iic
structur
featur
group
ii
spla
possess
extra
sequenc
middl
region
thu
cystein
ie
disulfid
although
spla
iic
express
abundantli
meiotic
cell
rodent
testi
pseudogen
human
therefor
analysi
mice
perform
cell
biolog
studi
use
knockdown
shown
spla
iic
upregul
hepat
binfect
hepatocyt
produc
lpe
present
natur
killer
cell
lead
propag
antiviru
immun
respons
atyp
group
xii
subfamili
contain
two
isoform
spla
xiia
xiib
vivo
function
spla
xiia
larg
obscur
sinc
studi
use
mice
yet
report
spla
xiia
kill
gramneg
bacteria
helicobact
pylori
even
effici
spla
iia
bactericid
spla
vitro
forcibl
overexpress
spla
xiia
xenopu
laevi
embryo
facilit
olfactori
sensori
neurogenesi
spla
xiia
present
axon
termin
dendrit
rat
brain
inject
antisens
oligonucleotid
prefront
cortex
perturb
work
memori
attent
spla
xiib
preferenti
express
liver
catalyt
inact
due
replac
catalyt
histidin
leucin
residu
mice
lack
spla
xiib
display
steatohepat
due
impair
hepat
secret
verylowdens
lipoprotein
unknown
probabl
noncatalyt
mechan
studi
last
decad
reveal
pathophysiolog
function
variou
spla
among
spla
iid
iie
iif
iii
highlight
review
clear
individu
spla
play
uniqu
tissuespecif
role
act
extracellular
phospholipid
includ
adjac
cell
membran
noncellular
lipid
compon
foreign
phospholipid
microb
food
divers
target
phospholipid
product
may
explain
spla
famili
contain
multipl
isoform
howev
knowledg
spla
function
obtain
mous
mostli
studi
import
translat
studi
human
caution
although
current
data
obtain
knockout
studi
suggest
individu
spla
function
nonredund
case
possibl
function
could
compens
spla
iia
normal
express
fulli
rule
analys
research
field
integr
therapeut
applic
benefit
advanc
lipidom
monitor
spla
associ
lipid
metabol
occur
within
specif
tissu
nich
detail
hope
next
decad
yield
comprehens
map
spla
driven
lipid
network
allow
develop
therapeut
applic
new
class
spla
inhibitor
transpar
document
associ
articl
found
onlin
version
